News
EAST RUTHERFORD, N.J., April 12, 2022 /PRNewswire/ -- Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing ...
Expanded capacity in Nansha, China, will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial productionCapabilities add to Lonza’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback